← FDA DRUG APPROVALS

FDA ANDA · ANDA070660

METOCLOPRAMIDE HYDROCHLORIDE

Sponsor: MUTUAL PHARM

APPLICATION
ANDA070660
TYPE
ANDA
ORIGINAL APPROVAL
1987-02-10
LATEST ACTION
1998-12-01
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

METOCLOPRAMIDE HYDROCHLORIDEDiscontinued
METOCLOPRAMIDE HYDROCHLORIDE EQ 10MG BASE · TABLET · ORAL

Approval history

1998-12-01Manufacturing (CMC) · Supplement 15AP
1994-12-23Manufacturing (CMC) · Supplement 14AP
1994-10-11Manufacturing (CMC) · Supplement 13AP
1992-04-03Manufacturing (CMC) · Supplement 12AP
1992-04-03Manufacturing (CMC) · Supplement 10AP
1990-01-30Labeling · Supplement 9AP
1989-11-13Labeling · Supplement 8AP
1989-08-31Labeling · Supplement 7AP
1989-08-31Labeling · Supplement 6AP
1989-03-23Labeling · Supplement 5AP
1988-09-29Labeling · Supplement 4AP
1987-04-23Labeling · Supplement 2AP
1987-04-01Manufacturing (CMC) · Supplement 1AP
1987-02-10OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →